Doctor profile · Federal record
Dr. FARIA AMJAD, MD
Neurology Physician (CMS: NEUROLOGY) · Neurology Physician · Neurology Physician · WASHINGTON, DC
- NPI 1518285204
- Accepts Medicare
- MIPS 75.7 / 100 · 2023
- 17 yrs in practice
- Licensed in 3 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3800 RESERVOIR RD NW, DEPT OF NEUROLOGY, PHC 7
WASHINGTON, DC 200072113
(202) 444-7078
fax (202) 444-0686
Credentials & registration
- NPI registered
- May 2010 — 16 yrs on file
- Profile last updated
- October 14, 2021
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State licenses (3)
- District of Columbia #MD041499 · Maryland #D0078373 · Virginia #0101256872
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1518285204. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
602
Distinct HCPCS
9
Medicare allowed
$98,780
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 224 | 135 | $196 | |
J0475 |
Injection, baclofen, 10 mg | 152 | 17 | $168 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 52 | 36 | $144 | |
62370 |
Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | 46 | 17 | $107 | |
95874 |
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 31 | 16 | $92 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 28 | 28 | $246 | |
64642 |
Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 24 | 16 | $170 | |
G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 23 | 16 | $35 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 22 | 15 | $102 |
In context: peer comparison
Among 34 peers in this city , average services per provider: 406. This provider delivers 1.5× the peer median.Open Payments
Industry payments received
All-time total
$64,290
Transactions
162
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| TG Therapeutics, Inc. | 14 | $21,959.46 | |
| Genentech USA, Inc. | 17 | $13,840.23 | |
| E.R. Squibb & Sons, L.L.C. | 16 | $13,462.18 | |
| Alexion Pharmaceuticals, Inc. | 7 | $9,499.06 | |
| Amgen Inc. | 22 | $2,010.17 | |
| Celgene Corporation | 10 | $1,212.39 | |
| Novartis Pharmaceuticals Corporation | 30 | $1,111.22 | |
| ANI Pharmaceuticals, Inc. | 13 | $264.87 | |
| ABBVIE INC. | 10 | $261.55 | |
| Biogen, Inc. | 10 | $182.13 | |
| ACADIA Pharmaceuticals Inc | 4 | $87.30 | |
| MDD US Operations, LLC | 2 | $71.45 | |
| Ipsen Biopharmaceuticals, Inc | 3 | $54.74 | |
| Lilly USA, LLC | 2 | $43.11 | |
| Eisai Inc. | 2 | $42.31 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
541
Patients
93
Total drug cost
$963,728
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Baclofen | Generic | 96 | 35 | $6,069 |
| Gabapentin | Generic | 81 | 26 | $2,496 |
| Dalfampridine Er (Dalfampridine) | Brand | 62 | 14 | $31,775 |
| Kesimpta Pen (Ofatumumab) | Brand | 58 | 0 | $673,538 |
| Oxybutynin Chloride Er (Oxybutynin Chloride) | Brand | 54 | 18 | $1,243 |
| Duloxetine Hcl | Generic | 35 | 0 | $1,313 |
| Amantadine (Amantadine Hcl) | Brand | 23 | 0 | $2,190 |
| Dimethyl Fumarate | Generic | 23 | 0 | $56,562 |
| Tizanidine Hcl | Generic | 22 | 0 | $391 |
| Myrbetriq (Mirabegron) | Brand | 17 | 0 | $12,155 |